V
Vittorio Quagliuolo
Researcher at Humanitas University
Publications - 116
Citations - 2914
Vittorio Quagliuolo is an academic researcher from Humanitas University. The author has contributed to research in topics: Sarcoma & Soft tissue sarcoma. The author has an hindex of 23, co-authored 99 publications receiving 2204 citations. Previous affiliations of Vittorio Quagliuolo include University of Siena & University of Milan.
Papers
More filters
Journal ArticleDOI
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
Alessandro Gronchi,Stefano Ferrari,Vittorio Quagliuolo,Javier Martin Broto,Antonio López Pousa,Giovanni Grignani,Umberto Basso,Jean-Yves Blay,Oscar Tendero,Robert Diaz Beveridge,Virginia Ferraresi,Iwona Lugowska,Domenico Franco Merlo,Valeria Fontana,Emanuela Marchesi,Davide Maria Donati,Elena Palassini,Emanuela Palmerini,Rita De Sanctis,Carlo Morosi,Silvia Stacchiotti,Silvia Bagué,Jean Michelle Coindre,Angelo Paolo Dei Tos,Piero Picci,Paolo Bruzzi,Paolo G. Casali +26 more
TL;DR: This international, open-label, randomised, controlled, phase 3, multicentre trial aimed to show the superiority of the neoadjuvant administration of histotype-tailored regimen to standard chemotherapy.
Journal ArticleDOI
Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.
Umberto Veronesi,Franco Rilke,Alberto Luini,Virgilio Sacchini,Viviana Galimberti,Tiziana Campa,Emanuela Dei Bei,Marco Greco,Andrea Magni,M. Merson,Vittorio Quagliuolo +10 more
TL;DR: Five hundred and thirty‐nine patients with carcinoma of the breast treated with total axillary dissection and with positive axillary nodes were evaluated, finding the predicting value of the first level is considerable: when the nodes of the second level are clear the chances that metastatic nodes are present at the second and third levels are negligible.
Journal ArticleDOI
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas : a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
Alessandro Gronchi,Sergio Frustaci,Mario Mercuri,Javier Martin,Antonio Lopez-Pousa,Paolo Verderio,Lidia Mariani,Pinuccia Valagussa,Rosalba Miceli,Silvia Stacchiotti,Angelo Paolo Dei Tos,Antonino De Paoli,Alessandra Longhi,Andres Poveda,Vittorio Quagliuolo,Alessandro Comandone,Paolo G. Casali,Piero Picci +17 more
TL;DR: In this population of patients with high-risk localized STS, three cycles of full-dose preoperative CT were not inferior to five cycles of the same CT and the outcome compares favorably with the expected survival.
Journal ArticleDOI
Chordoma: Natural history and treatment results in 33 cases
Alberto Azzarelli,Vittorio Quagliuolo,Serenella Cerasoli,Roberto Zucali,P. Bignami,Vincenzo Mazzaferro,Giovanni Dossena,Leandro Gennari +7 more
TL;DR: The possibility of achieving radicality with high resection of the sacrum for lesions confined below the second sacral vertebra is confirmed, and the best treatment for unresectable lesions seems to be palliative surgery plus radiotherapy.
Journal ArticleDOI
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.
Giovanni de Manzoni,Daniele Marrelli,Gian Luca Baiocchi,Paolo Morgagni,Luca Saragoni,Maurizio Degiuli,Annibale Donini,Uberto Fumagalli,Maria Antonietta Mazzei,F Pacelli,Anna Tomezzoli,Mattia Berselli,F. Catalano,Alberto Di Leo,Massimo Framarini,S. Giacopuzzi,Luigina Graziosi,Alberto Marchet,Mario Marini,Carlo Milandri,Gianni Mura,Elena Orsenigo,Vittorio Quagliuolo,Stefano Rausei,Riccardo Ricci,Fausto Rosa,Giandomenico Roviello,Andrea Sansonetti,Giovanni Sgroi,Guido Alberto Massimo Tiberio,G. Verlato,Carla Vindigni,Riccardo Rosati,Franco Roviello +33 more
TL;DR: This article reports the guidelines for gastric cancer staging and treatment developed by the GIRCG, and contains comprehensive indications for clinical management, including radiological, endoscopic, surgical, pathological, and oncological paths.